CD163 and breast carcinoma: Interestingly, although high DEK/CD163 dual expression did not correlate with RFS in basal subtype or HER2+ breast cancer (Figure 5D,E), there was a strong correlation with decreased RFS in luminal A subtype (Figure 5F) and a similar correlation with luminal B subtype (data not shown).